- Macule: Nonpalpable, <1 cm
- Patch: Nonpalpable, >1 cm
- Papule: Solid, palpable, <1 cm
- Nodule: Solid, palpable, 1–2 cm, dermal
- Tumor: Solid, palpable, >2 cm
- Plaque: Solid, palpable, >1 cm, width > thickness
- Vesicle: Raised, clear, fluid filled, <1 cm
- Bulla: Raised, clear, fluid filled, >1 cm
- Pustule: Raised, pus filled
- Wheal: Transient, palpable edema
- Scale: Accumulation of loosely adherent keratin
- Crust: Accumulation of serum, cellular, bacterial, and squamous debris over damaged epidermis
- Fissure: Superficial, often painful break in epidermis
- Erosion: Loss of epidermis; heals without scarring
- Ulcer: Loss of epidermis and part or all of dermis; heals with scarring
- Excoriation: Linear erosion
- Lichenification: Accentuated skin markings caused by thickening of epidermis; usually caused by scratching or rubbing
- Scar: Fibrous tissue replacing normal architecture of dermis
- Atrophy: Epidermal (thinning of epidermis) or dermal (decrease in the amount of collagen or causing depression of skin)
Description | Distribution | Duration | Exposure | Signs and Symptoms |
---|---|---|---|---|
|
|
|
|
|
- Risk factors: Family history, other atopic diseases (asthma, allergic rhinitis), food hypersensitivity, environmental allergens
- Clinical manifestations: Pruritic, erythematous, scaly papules and plaques → edema, serous discharge, crusting → lichenification, hyperpigmentation, fissuring → superinfection (primarily with Staphylococcus aureus; also with HSV)
Type | Clinical Features | Treatment or Prevention |
---|---|---|
S. aureus superinfection | Honey-crusted erosions, pustules, weeping, acute increase in erythema |
|
Eczema herpeticum (HSV superinfection)
|
|
|
Long-term TCS use |
|
|
Postinflammatory pigment changes |
| Sun protection and continued treatment of flares of dermatitis |
- Maintenance: Short, lukewarm baths or showers under 10 minutes with mild soap; frequent moisturization with thick, bland emollients (cream or ointment)
- Mild flare: Class 6 to 7 TCS or TCI BID (approved for ≥2 yo; use for ≤2 weeks at a time; good for face); ointment preferred
- Moderate flare: Midpotency TCS for body BID (eg, triamcinolone 0.1%); ointment preferred; class 6 to 7 TCS or TCI BID for face; oral antihistamines PRN for pruritus
- Severe flare: Midpotency TCS followed by warm, wet wraps BID for at least 15 min; ointment preferred; then application of emollient; oral antihistamines PRN for pruritus and antibiotics for superinfection
Type | Description | Causes | Course | Treatment |
---|---|---|---|---|
Irritant |
| Results from contact with a substance that chemically or physically damages skin
|
|
|
Allergic (type IV cell- mediated immune reaction) |
|
|
|
|
Disease | Description | Course | Treatment | Other |
---|---|---|---|---|
Seborrheic dermatitis (infantile form) |
|
|
|
|
Keratosis pilaris* |
|
|
|
|
Pityriasis alba |
|
| Emollients, low-potency TCS, sunscreen | |
Pityriasis rosea |
|
|
|
|
Psoriasis‡ |
|
|
|
|
Type | Description | Pathogenesis | Treatment | Course |
---|---|---|---|---|
Mild comedonal | Open comedones (blackheads) or closed comedones (whiteheads) | Accumulation of keratinous debris in pilosebaceous unit → occlusion of follicles → sebum accumulation | Topical retinoid ± BPO | Continue treatment for at least 2–3 mo |
Moderate to severe comedonal | Same but more extensive | |||
Mild inflammatory | Scattered small papules or pustules | Proliferation of Propionibacterium acnes → inflammation | Topical retinoid ± topical antibiotic ± BPO |
|
Moderate inflammatory | Generalized papules or pustules on face or trunk | Topical retinoid ± oral antibiotic ± BPO | ||
Nodulocystic | Large, deep inflammatory nodules, cysts | Isotretinoin |
|
Treatment Type | Mechanism | Dose | Side Effects | Monitoring |
---|---|---|---|---|
BPO | Bactericidal | 2.5%, 5%, and 10% gel, liquid, cream | Dryness, irritation, desquamation, may bleach clothing | |
Topical retinoid (tretinoin, adapalene, tazarotene) | Normalizes keratinocyte desquamation, anti-inflammatory | Use highest concentration tolerated, pea-sized amount every evening | Dryness, desquamation, irritation, photosensitivity | |
Topical antibiotics | Eliminate P. acnes from follicles | Erythromycin 2% solution, clindamycin 1% solution | Rarely pseudomembranous colitis with clindamycin | |
Systemic antibiotics | Reduce resident skin bacteria, inhibit neutrophil chemotaxis, alter macrophage and cytokine production |
|
| Use Tetracycline, Doxycycline, Minocycline only in patients >8 yo |
Isotretinoin | Reduce sebum secretion → decreased P. acnes proliferation, inhibits comedogenesis, anti-inflammatory properties | Total treatment course of 120–150 mg/kg over 4-6+ mo | Teratogenicity, cheilitis, dryness, peeling, photosensitivity, pruritus, hypertriglyceridemia, possible association with depression or suicide,* hepatoxicity, bone marrow suppression, pseudotumor cerebri, IBD† |
|
Hormonal | Blocks androgen production → reduces sebum production |
|
|
|
Type | Description | Course | Treatment | Other |
---|---|---|---|---|
Hemangioma |
|
|
|
|
Capillary malformation (port wine stain, nevus flammeus) |
|
|
|
|